Squalamine ointment for Staphylococcus aureus skin decolonization in a mouse model

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 6, 2011, Pages 1306-1310

  Djouhri Bouktab, Lamia ^a   Alhanout, Kamel ^a   Andrieu, Véronique ^a   Raoult, Didier ^a   Rolain, Jean Marc ^a   Brunel, Jean Michel ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Aminosterol derivatives; Mouse skin model; S. aureus

Indexed keywords

AMINOSTEROL DERIVATIVE 2; ANTIBIOTIC AGENT; FUSIDATE SODIUM; PSEUDOMONIC ACID; SQUALAMINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANTIBIOTIC SENSITIVITY; ANTISEPSIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL LOAD; BACTERIAL STRAIN; CELL COUNT; CELL VIABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; NOSE; OINTMENT; PREOPERATIVE PERIOD; SKIN DECONTAMINATION; STAPHYLOCOCCUS AUREUS;

EID: 79955998031     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr114     Document Type: Article

References (27)

1. Burian M, Wolz C, Goerke C. Regulatory adaptation of Staphylococcus aureus during nasal colonization of humans. PLoS One 2010; 5: e10040.
2. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10: 505-20.
3. Bode LG, Kluytmans JA, Wertheim HF et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010; 362: 9-17.
4. Edmiston CE Jr, Krepel CJ, Seabrook GR et al. Preoperative shower revisited: can high topical antiseptic levels be achieved on the skin surface before surgical admission? J Am Coll Surg 2008; 207: 233-9.
5. Semret M, Miller MA. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains. Infect Control Hosp Epidemiol 2001; 22: 578-80.
6. Yano M, Doki Y, Inoue M et al. Preoperative intranasal mupirocin ointment significantly reduces postoperative infection with Staphylococcus aureus in patients undergoing upper gastrointestinal surgery. Surg Today 2000; 30: 16-21.
7. Howden BP, Grayson ML. Dumb and dumber-the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus. Clin Infect Dis 2006; 42: 394-400.
8. Falagas ME, Bliziotis IA, Fragoulis KN. Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials. Am J Infect Control 2007; 35: 106-14.
9. van Rijen M, Bonten M, Wenzel R et al. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 2008; issue 4: CD006216.
10. Morton TM, Johnston JL, Patterson J et al. Characterization of a conjugative staphylococcal mupirocin resistance plasmid. Antimicrob Agents Chemother 1995; 39: 1272-80.
11. Cookson BD. Mupirocin resistance in staphylococci. J Antimicrob Chemother 1990; 25: 497-501.
12. Kokai-Kun JF, Walsh SM, Chanturiya T et al. Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model. Antimicrob Agents Chemother 2003; 47: 1589-97.
13. Darouiche RO, Wall MJ Jr, Itani KM et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 2010; 362: 18-26.
14. Krishna BV, Gibb AP. Use of octenidine dihydrochloride in meticillin-resistant Staphylococcus aureus decolonisation regimens: a literature review. J Hosp Infect 2010; 74: 199-203.
15. Moore KS, Wehrli S, Roder H et al. Squalamine: an aminosterol antibiotic from the shark. Proc Natl Acad Sci USA 1993; 90: 1354-8.
16. Zhang DH, Cai F, Zhou XD et al. A concise and stereoselective synthesis of squalamine. Org Lett 2003; 5: 3257-9.
17. Alhanout K, Brunel JM, Raoult D et al. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis. J Antimicrob Chemother 2009; 64: 810-4.
18. Alhanout K, Malesinki S, Vidal N et al. New insights into the antibacterial mechanism of action of squalamine. J Antimicrob Chemother 2010; 65: 1688-93.
19. Salmi C, Loncle C, Vidal N et al. New stereoselective titanium reductive amination synthesis of 3-amino and polyaminosterol derivatives possessing antimicrobial activities. Eur J Med Chem 2008; 43: 540-7.
20. Rolain JM, Francois P, Hernandez D et al. Genomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage. Biol Direct 2009; 4: 1.
21. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001; 48 Suppl 1: 5-16.
22. Onunkwo CC, Hahn BL, Sohnle PG. Clearance of experimental cutaneous Staphylococcus aureus infections in mice. Arch Dermatol Res 2010; 302: 375-82.
23. Kiser KB, Cantey-Kiser JM, Lee JC. Development and characterization of a Staphylococcus aureus nasal colonization model in mice. Infect Immun 1999; 67: 5001-6.
24. Kokai-Kun JF. The cotton rat as a model for Staphylococcus aureus nasal colonization in humans: cotton rat S. aureus nasal colonization model. Methods Mol Biol 2008; 431: 241-54.
25. Reynaud AE, Espaze EP, Coste-Burel M et al. In vitro kinetics of the activity of fusidic acid and fluoroquinolones combinations against staphylococci according to methicillin-resistance phenotype. Implications for the treatment of osteoarticular infections. Pathol Biol (Paris) 1992; 40: 466-70.
26. LaPlante KL. In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 2007; 57: 413-8.
27. Daniel A, Euler C, Collin M et al. Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillinresistant Staphylococcus aureus. Antimicrob Agents Chemother 2010; 54: 1603-12.